Ca2+ channel currents in type I carotid body cells from normoxic and chronically hypoxic rats.
Carpenter
E
E
Institute for Cardiovascular Research, Leeds University, UK.
Wyatt
C N
CN
Hatton
C J
CJ
Bee
D
D
Peers
C
C
D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000145:classification / Q000187:drug effects / Q000378:metabolism*; D020746:Calcium Channels, L-Type; D002344:Carotid Body / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D015687:Cell Hypoxia; D002478:Cells, Cultured; D002908:Chronic Disease; D000860:Hypoxia / Q000151:congenital / Q000378:metabolism*; D017136:Ion Transport / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000187:drug effects / Q000378:metabolism*; D009543:Nifedipine / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D051381:Rats; D020866:omega-Conotoxin GVIA
D002121:Calcium Channel Blockers; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D009419:Nerve Tissue Proteins; D010455:Peptides; C053157:omega-conotoxin receptor; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; D020866:omega-Conotoxin GVIA; D009543:Nifedipine; D002118:Calcium